Search

everythinglearnresearchcommunity

for

Search:↓

Polymeric nanoparticles show promise for treating skin diseases.

Minoxidil and finasteride treat hair loss in men, while minoxidil treats hair loss in women.

Hair loss common in Australia; men affected earlier, more often than Asians; women less concerned.

Coal tar shampoos, salicylic acid, and topical corticosteroids are effective for scalp psoriasis, with Vitamin D3 analogues also showing benefits; severe cases may require stronger medication with more risks.

Different hair evaluation methods have their own pros and cons, and using multiple methods together is best for accurate hair loss diagnosis and tracking.

Mutant mice help researchers understand hair growth and related genetic factors.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Female pattern hair loss can be treated with medications, surgery, and cosmetic products, considering its psychological impact.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

Finasteride effectively treats male pattern baldness, improving hair growth and density.

Women with AGA often face anxiety, depression, and low self-esteem; psychological support is important.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Stem cells help repair tissue mainly by releasing beneficial substances, not by replacing damaged cells.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The document concludes that understanding and treating hair loss requires recognizing its various types and using appropriate diagnostic tools and treatments.

The conclusion is that we need more effective hair loss treatments than the current ones, and these could include new drugs, gene and stem cell therapy, hormones, and scalp cooling, but they all need thorough safety testing.

The Trichoscan system was found to be inaccurate for measuring hair growth, needing better software to be useful.

Female hair loss linked to metabolic syndrome, not in males.

Alopecia is linked to various health and mental conditions, impacts life quality, and needs medical attention beyond its cosmetic effects.

Minoxidil effectively treats female pattern hair loss.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hair loss in women not always linked to increased oil production; other factors may be involved.

FUE hair transplants offer minimal scarring and are good for short hairstyles but are time-consuming and can be costly.

Commercial hair loss websites promote Propecia by making men feel insecure about baldness and suggesting it's a medical issue needing treatment.

Spironolactone may effectively treat female hair loss, especially with hyperandrogenism signs.

The document concludes that it's important to understand the placebo effect when evaluating the effectiveness of treatments in medical trials.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.